Mouse Monoclonal RUNX3 antibody. Suitable for Flow Cyt, WB, IHC-P, ICC/IF and reacts with Mouse, Human samples. Cited in 20 publications. Immunogen corresponding to Recombinant Fragment Protein within Human RUNX3 aa 150-300.
View Alternative Names
AML2, CBFA3, PEBP2A3, RUNX3, Runt-related transcription factor 3, Acute myeloid leukemia 2 protein, Core-binding factor subunit alpha-3, Oncogene AML-2, Polyomavirus enhancer-binding protein 2 alpha C subunit, SL3-3 enhancer factor 1 alpha C subunit, SL3/AKV core-binding factor alpha C subunit, CBF-alpha-3, PEA2-alpha C, PEBP2-alpha C
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX3 antibody [2B3] (AB135248)
Immunohistochemical analysis of Paraffin-embedded Human cervical cancer tissue labelling RUNX3 with ab135248 at 1/200 dilution followed by DAB staining.
- Flow Cyt
Unknown
Flow Cytometry - Anti-RUNX3 antibody [2B3] (AB135248)
Flow cytometric analysis of NIH 3T3 cells labelling RUNX3 with ab135248 at 1/200 dilution (green). Negative control (red).
- WB
Lab
Western blot - Anti-RUNX3 antibody [2B3] (AB135248)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : RUNX3 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab135248 observed at 44 kDa. Red - loading control, ab176560, observed at 50 kDa.
ab135248 was shown to recognize RUNX3 in wild-type HAP1 cells as signal was lost at the expected MW in RUNX3 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and RUNX3 knockout samples were subjected to SDS-PAGE. ab135248 and ab176560 (Rabbit anti-alpha Tubulin loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed ab216772 and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed ab216777 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RUNX3 antibody [2B3] (ab135248)
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-RUNX3 antibody [2B3] (AB135248)
All lanes:
Western blot - Anti-RUNX3 antibody [2B3] (ab135248) at 1/500 dilution
Lane 1:
HEK293 cell lysate, non-transfected
Lane 2:
HEK293 cell lysate, transfected with RUNX3 (amino acids 186-252)-hIgGFc
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-RUNX3 antibody [2B3] (AB135248)
All lanes:
Western blot - Anti-RUNX3 antibody [2B3] (ab135248) at 1/500 dilution
All lanes:
Recombinant Human RUNX3 protein
Predicted band size: 44 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of RUNX3 involves the regulation of cell proliferation differentiation and apoptosis. RUNX3 often forms a complex with the core-binding factor beta (CBFβ) enhancing its stability and DNA-binding capability. This protein is essential in maintaining cellular homeostasis and influencing the immune response particularly through its role in T cell development.
Pathways
RUNX3 is heavily involved in the TGF-beta signaling pathway and the Wnt signaling pathway. It interacts with several proteins such as SMADs in the TGF-beta pathway to modulate gene expression that affects cell growth and survival. Interaction with beta-catenin in the Wnt signaling pathway further emphasizes its importance in regulating cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Journal of inflammation research 18:6305-6317 PubMed40395555
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMJ open respiratory research 11: PubMed39521608
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 28:104 PubMed38093179
2023
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 35:101727 PubMed37354639
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed36900240
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 17:1579-1590 PubMed36518886
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6187 PubMed36261443
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:5752263 PubMed35368900
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 207:2976-2991 PubMed34810221
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 19:469 PubMed34798872
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com